Clinical study for the treatment of white patches (vitiligo) with unani and allopathic medicine

A Randomized, Active-Controlled, Assessor-Blinded, Parallel Group Clinical Study to compare the Safety and Efficacy of Polyherbal Unani Formulations (O â?? T) with PUVAsol and Mometasone in the Management of Baraá¹£ (Vitiligo)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028107

Enrollment

Registered

2020-09-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: PUF (O): Oral (Maâ??jÅ«n). PUF (T): Topical (á¸?imÄ?d: Powder mixed with honey): Oral PUF (Maâ??jÅ«n): Patients will be advised to take 7.5 gm Maâ??jÅ«n, orally twice daily an hour afte

Eligibility

Inclusion criteria

Inclusion criteria: all age groups from 19 years to 60 years of age

Exclusion criteria

Exclusion criteria: age below 19 years age above 60 years

Design outcomes

Primary

Measure	Time frame
Reduction in vitiligo area scoring index VASI VIDA PGA IGATimepoint: Baseline and After treatment	—

Secondary

Measure	Time frame
chest x - ray ECG LABORATORY INVESTIGATIONSTimepoint: 0,4,8,12,16 WEEKS	—

Countries

India

Contacts

Public ContactProf Qamaruddin

National Research Institute of Unani Medicine for Skin Disorders

ccrumhqrsnd58@gmail.com8700027178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026